Charles S. Fuchs

Dr. Fuchs is Director of the Center for Gastrointestinal Cancer at Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School. He also leads the Dana-Farber Harvard Cancer Center Gastrointestinal Malignancies Program and the DF/HCC SPORE Grant in Gastrointestinal Cancers, and he is the extramural leader for the NCI-sponsored Genome-Wide Association Study in Pancreatic Cancer (PanScan). Dr. Fuchs splits his time between laboratory-based research, clinical research, and clinical care. His laboratory focuses on biochemical markers of gastrointestinal cancer risk, molecular predictors of patient prognosis in colorectal and pancreatic cancers, and the discovery of novel targets for cancer therapy. Dr. Fuchs has also led numerous national and international clinical trials assessing novel targeted therapies for GI malignancies. Dr. Fuchs is a member of the Scientific Advisory Board for the Lustgarten Foundation for Pancreatic Cancer and a cadre member of GI Committee for Cancer and Leukemia Group B. Dr. Fuchs has over 270 scientific publications in such journals as The New England Journal of Medicine, Journal of the American Medical Association, Journal of Clinical Oncology, Cell, and Nature.